Arthur Eichengrün the invention of aspirin in 1897. Impure acetylsalicylic acid (ASA, the active compound of aspirin) had been synthesized already in 1853 by French chemist Charles Frédéric Gerhardt; the 1897 process developed at Bayer was the first to produce pure ASA that could be used for medical purposes. Due to the rise of the Nazis in Germany, Eichengrün was unable to object when Hoffman first made the claim that "he" (Hoffman) invented aspirin, in the footnote of a 1934 German Encyclopedia. Hoffman's claim was once widely accepted, but many historians now consider it to be discredited. Eichengrün first claimed to have
Lymphatic endothelium vessels considered less important. Later it was discovered that VEGF-R3 and VEGF-C/VEGF-D were the key growth factors controlling lymphatic endothelial proliferation. Markers of lymphatic endolthelium were not discovered until relatively recently. These being LYVE-1 (Jackson et al.,1999) and podoplanin (Kerjaschki,1999). Endothelium Lymphatic endothelium The lymphatic endothelium is a specialised form of epithelium, distinct from but similar to vascular endothelium. A lymph capillary endothelial cell is distinct from other endothelial cells in that collagen fibers are directly attached to its plasma membrane. Although lymphatics were first described by Hippocrates in 400BC and rediscovered as "milky veins in the gut of a